GFC Life Science Co., Ltd (KOSDAQ:388610)
10,190
+60 (0.59%)
At close: Mar 6, 2026
-25.62% (1Y)
| Market Cap | 50.11B |
| Revenue (ttm) | 13.74B |
| Net Income (ttm) | 1.62B |
| Shares Out | 5.26M |
| EPS (ttm) | 1,560.00 |
| PE Ratio | 6.01 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,210 |
| Average Volume | 59,430 |
| Open | 10,200 |
| Previous Close | 10,130 |
| Day's Range | 9,920 - 10,240 |
| 52-Week Range | 9,740 - 40,000 |
| Beta | 1.13 |
| RSI | 22.42 |
| Earnings Date | Mar 18, 2026 |